Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription 02.09.2019 2 BMJ 1 J Immunol 1 J Infect Dis 2 J Virol 1 JAMA 1 Pediatr Infect Dis J 3 PLoS One 1 Proc Natl Acad Sci U S A 18 Vaccine 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMJ

1. MAHASE E
   Stop funding expensive pneumonia vaccine, MSF urges vaccine alliance.
   BMJ. 2019;366:l5303.
   PubMed     Text format    
   
   
2. ZUMLA A, Memish ZA
   Risk of antibiotic resistant meningococcal infections in Hajj pilgrims.
   BMJ. 2019;366:l5260.
   PubMed     Text format    
   
   

   
   J Immunol

3. KAO YS, Yu CY, Huang HJ, Tien SM, et al
   Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection.
   J Immunol. 2019 Aug 26. pii: jimmunol.1900136. doi: 10.4049/jimmunol.1900136.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

4. FEDSON DS
   Statins, Influenza Vaccination and Influenza.
   J Infect Dis. 2016.
   PubMed     Text format    
   
   

   
   J Virol

5. JOHNSON J, Freedman H, Logan M, Wong JAJ, et al
   A recombinant HCV genotype 1a E1/E2 envelope glycoprotein vaccine elicits antibodies that differentially neutralize closely related 2a strains through interactions of the N-terminal hypervariable region 1 of E2 with scavenger receptor B1.
   J Virol. 2019 Aug 28. pii: JVI.00810-19. doi: 10.1128/JVI.00810.
   PubMed     Text format     Abstract available
   
   
6. SLIVA K, Martin J, von Rhein C, Herrmann T, et al
   Interference with SAMHD1 restores late gene expression of modified vaccinia virus Ankara (MVA) in human dendritic cells and abrogates type I interferon expression.
   J Virol. 2019 Aug 28. pii: JVI.01097-19. doi: 10.1128/JVI.01097.
   PubMed     Text format     Abstract available
   
   

   
   JAMA

7. CHUN TW, Eisinger RW, Fauci AS
   Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles.
   JAMA. 2019 Jun 6. pii: 2735725. doi: 10.1001/jama.2019.5397.
   PubMed     Text format    
   
   

   
   Pediatr Infect Dis J

8. LIN L, Macias Parra M, Sierra VY, Salas Cespedes A, et al
   Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Vaccine in Four- to Six-year-old Girls: Three-year Follow-up of a Randomized Phase III Trial.
   Pediatr Infect Dis J. 2019 Aug 28. doi: 10.1097/INF.0000000000002437.
   PubMed     Text format     Abstract available
   
   

   
   PLoS One

9. JUSTWAN F, Baumgaertner B, Carlisle JE, Carson E, et al
   The effect of trust and proximity on vaccine propensity.
   PLoS One. 2019;14:e0220658.
   PubMed     Text format     Abstract available
   
   
10. BITSOUNI V, Lycett S, Opriessnig T, Doeschl-Wilson A, et al
    Predicting vaccine effectiveness in livestock populations: A theoretical framework applied to PRRS virus infections in pigs.
    PLoS One. 2019;14:e0220738.
    PubMed     Text format     Abstract available
    
    
11. FERRERAS E, Matapo B, Chizema-Kawesha E, Chewe O, et al
    Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.
    PLoS One. 2019;14:e0219040.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

12. FELDMAN MF, Mayer Bridwell AE, Scott NE, Vinogradov E, et al
    A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae.
    Proc Natl Acad Sci U S A. 2019 Aug 27. pii: 1907833116.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

13. JACOBSEN KH, McCoy JD, Painter JE
    Authors' Response "Perceptions of vaccination within a Christian homeschooling community in Pennsylvania".
    Vaccine. 2019;37:5667.
    PubMed     Text format    
    
    
14. LAN H, Hosomi K, Kunisawa J
    Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system.
    Vaccine. 2019 Aug 26. pii: S0264-410X(19)31096.
    PubMed     Text format     Abstract available
    
    
15. PINDYCK T, Tate JE, Bonkoungou IJO, Armah G, et al
    Timeliness of rotavirus vaccination at sentinel sites in four early-adopter African countries.
    Vaccine. 2019 Aug 24. pii: S0264-410X(19)31047.
    PubMed     Text format     Abstract available
    
    
16. PARK BJ, Ahn HS, Han SH, Go HJ, et al
    Evaluation of the protective effects of a nanogel-based vaccine against rabbit hepatitis E virus.
    Vaccine. 2019 Aug 24. pii: S0264-410X(19)31093.
    PubMed     Text format     Abstract available
    
    
17. KOFF WC, Schenkelberg T
    The future of vaccine development.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31022.
    PubMed     Text format     Abstract available
    
    
18. PACKNETT E, Irwin DE, Novy P, Watson PS, et al
    Meningococcal-group B (MenB) vaccine series completion and adherence to dosing schedule in the United States: A retrospective analysis by vaccine and payer type.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)30842.
    PubMed     Text format     Abstract available
    
    
19. XIA R, Sun S, Shen M, Zhang L, et al
    Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31040.
    PubMed     Text format     Abstract available
    
    
20. DAS M, Singh H, Girish Kumar CP, John D, et al
    Non-vaccine strategies for cholera prevention and control: India's preparedness for the global roadmap.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31049.
    PubMed     Text format     Abstract available
    
    
21. STREZOVA A, Lal H, Enweonye I, Campora L, et al
    The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged >/=50 years: A randomized trial.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31026.
    PubMed     Text format     Abstract available
    
    
22. FATHIMA P, Gidding HF, Snelling TL, McIntyre PB, et al
    Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31063.
    PubMed     Text format     Abstract available
    
    
23. ROZBROJ T, Lyons A, Lucke J
    The mad leading the blind: Perceptions of the vaccine-refusal movement among Australians who support vaccination.
    Vaccine. 2019 Aug 23. pii: S0264-410X(19)31073.
    PubMed     Text format     Abstract available
    
    
24. HOQUE SA, Iizuka I, Kobayashi M, Takanashi S, et al
    Determining effectiveness of rotavirus vaccine by immunochromatography and reverse transcriptase polymerase chain reaction: A comparison.
    Vaccine. 2019 Aug 22. pii: S0264-410X(19)31012.
    PubMed     Text format     Abstract available
    
    
25. ZUK P, Zuk P
    One of the recent attacks of smallpox in Europe: A massive vaccination campaign during the epidemic in Wroclaw in 1963.
    Vaccine. 2019 Aug 24. pii: S0264-410X(19)31102.
    PubMed     Text format     Abstract available
    
    
26. EVANS DR, Yemeke TT, Kiracho EE, Mutebi A, et al
    Trust in vaccines and medicines in Uganda.
    Vaccine. 2019 Aug 22. pii: S0264-410X(19)30913.
    PubMed     Text format     Abstract available
    
    
27. WILKINSON TMA, Schembri S, Brightling C, Bakerly ND, et al
    Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial.
    Vaccine. 2019 Aug 22. pii: S0264-410X(19)31021.
    PubMed     Text format     Abstract available
    
    
28. PAGLIUSI S, Che Y, Dong S
    The art of partnerships for vaccines.
    Vaccine. 2019 Aug 22. pii: S0264-410X(19)31009.
    PubMed     Text format     Abstract available
    
    
29. BRUXVOORT KJ, Luo Y, Ackerson B, Tanenbaum HC, et al
    Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018.
    Vaccine. 2019 Aug 21. pii: S0264-410X(19)31074.
    PubMed     Text format     Abstract available
    
    
30. NEALON J, Lim WY, Moureau A, Linus Lojikip S, et al
    Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia.
    Vaccine. 2019 Aug 21. pii: S0264-410X(19)31004.
    PubMed     Text format     Abstract available
    
    

    
    Virus Res

31. DIXON LK, Islam M, Nash R, Reis AL, et al
    African swine fever virus evasion of host defences.
    Virus Res. 2019;266:25-33.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: